2 days Sage Therapeutics: Looks Like A ‘Strong Buy’ With Zurzuvae’s Potential And Biogen’s Bid Seeking Alpha

Sage Therapeutics: Looks Like A ‘Strong Buy’ With Zurzuvae’s Potential And Biogen’s Bid.

Biogen (BIIB)